Safety and Efficacy of Low-dose IL-2 in Birch Pollen Allergy
Condition(s):Allergic Rhinoconjunctivitis to Birch Pollen; With a Positive Skin Prick Test to Birch PollenLast Updated:December 4, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Allergic Rhinoconjunctivitis to Birch Pollen; With a Positive Skin Prick Test to Birch PollenLast Updated:December 4, 2023Completed
Condition(s):Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:September 13, 2023Recruiting
Condition(s):COVID-19Last Updated:February 9, 2024Active, not recruiting
Condition(s):HemorrhageLast Updated:April 14, 2020Completed
Condition(s):Lymphoma; Leukemia; Myeloproliferative Disorders; Multiple Myleoma; Myelodysplastic SyndromeLast Updated:December 31, 2018Terminated
Condition(s):Hepatitis B, ChronicLast Updated:February 22, 2024Active, not recruiting
Condition(s):Amputation, Traumatic; Amputation;Traumatic;Old; Face Injury; Face; Deformity; Abdominal Wall DefectLast Updated:July 28, 2021Terminated
Condition(s):Virus DiseasesLast Updated:February 26, 2018Withdrawn
Condition(s):Heart Defects, Congenital; HyperglycemiaLast Updated:July 25, 2022Completed
Condition(s):Granulomatous Disease, Chronic, X-linked, VariantLast Updated:June 4, 2012Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.